US Broker Ratings

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: Unveiling a 90% Upside Potential

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) has garnered significant attention within the biotechnology sector, primarily due to its promising drug pipeline and strategic alliances with industry giants such as GlaxoSmithKline, Pfizer..

Kymera Therapeutics, Inc. (KYMR) Stock Analysis: A Compelling 38.40% Potential Upside with Strong Buy Ratings

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a pioneering biopharmaceutical company, has captured the attention of investors with its innovative approach to drug development and a notable potential upside of 38.40%. Headquartered..

Protagonist Therapeutics, Inc. (PTGX) Stock Report: Unveiling a 24% Potential Upside in the Biotech Sector

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) stands out in the competitive biotechnology sector, capturing the attention of investors with its promising pipeline and a significant potential upside. With a market capitalization..

Crinetics Pharmaceuticals, Inc. (CRNX) Stock Analysis: A 133% Potential Upside in the Biotech Sector

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX), a clinical-stage biotechnology company based in San Diego, California, is making waves in the healthcare sector. With a market capitalization of $2.8 billion, the company..

PROCEPT BioRobotics (PRCT) Stock Analysis: A Promising 62.67% Upside in the Healthcare Sector

For investors eyeing the healthcare sector, PROCEPT BioRobotics Corporation (NASDAQ: PRCT) represents a compelling opportunity with significant growth potential. The company’s focus on innovative medical devices in urology positions it..

CONMED Corporation (CNMD) Stock Analysis: Evaluating a 14.25% Upside Potential in the Medical Device Sector

Investors with a keen interest in the healthcare sector, particularly in the medical devices industry, may find CONMED Corporation (NASDAQ: CNMD) a noteworthy consideration. With a market capitalization of $1.65..

Ardent Health, Inc. (ARDT) Stock Analysis: 52.72% Potential Upside Ignites Investor Interest

Ardent Health, Inc. (ARDT) presents a compelling opportunity for investors seeking exposure in the healthcare sector, particularly within the medical care facilities industry. Based in Brentwood, Tennessee, and operating as..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: A 23.61% Upside Opportunity for Investors

Alignment Healthcare, Inc. (NASDAQ: ALHC) stands out in the healthcare sector with its impressive potential upside of 23.61%, making it a compelling consideration for investors eyeing growth opportunities. This Orange,..

Merus N.V. (MRUS) Stock Analysis: Exploring a 36.97% Potential Upside in Biotech

Merus N.V. (MRUS), a Netherlands-based biotechnology company, is making waves in the healthcare sector with its innovative approach to immuno-oncology. With a market capitalization of $4.99 billion, Merus is positioning..

LifeStance Health Group, Inc. (LFST) Investor Outlook: Navigating a Potential 55.8% Upside

LifeStance Health Group, Inc. (NASDAQ: LFST) stands as a noteworthy player in the healthcare sector, specifically within the medical care facilities industry. Specializing in outpatient mental health services across the..

Arrowhead Pharmaceuticals (ARWR) Stock Analysis: Unpacking a Potential 119.92% Upside

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) presents an intriguing opportunity in the biotechnology sector, standing at the crossroads of innovative drug development and promising market potential. With a substantial market capitalization..

Enovis Corporation (ENOV) Stock Analysis: Exploring a 76.65% Upside Potential in the Medical Devices Sector

Enovis Corporation (NYSE: ENOV), a specialist in medical technology, presents a compelling opportunity for investors with a potential upside of 76.65%, based on the average target price of $52.20. With..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: Evaluating a 29.59% Upside Potential

Amneal Pharmaceuticals, Inc. (AMRX), a leading player in the healthcare sector, is capturing attention with its robust market presence in the specialty and generic drug manufacturing industry. With a current..

Privia Health Group, Inc. (PRVA): Investor Outlook Highlights 40% Upside Potential

Privia Health Group, Inc. (NASDAQ: PRVA) is making waves in the healthcare sector with its innovative approach to physician enablement. Headquartered in Arlington, Virginia, this company has positioned itself as..

Concentra Group Holdings Parent (CON): Investor Outlook and 22% Upside Potential

Concentra Group Holdings Parent, Inc. (CON), a key player in the U.S. healthcare sector, particularly within the medical care facilities industry, stands out with a market capitalization of $2.93 billion...

CRISPR Therapeutics AG (CRSP) Stock Analysis: Potential 42% Upside Highlights Growth Potential

CRISPR Therapeutics AG (NASDAQ: CRSP), a pioneering force in the biotechnology sector, continues to captivate investor interest with its innovative gene-editing capabilities and promising pipeline. As the global leader in..

CG Oncology, Inc. (CGON) Investor Outlook: Analyzing a 129% Potential Upside in the Biotech Sector

Investors seeking opportunities in the biotechnology sector might find CG Oncology, Inc. (NASDAQ: CGON) an intriguing prospect, particularly given its impressive 129% potential upside. Specializing in innovative bladder cancer therapies,..

Warby Parker Inc. (WRBY) Stock Analysis: Navigating the Ups and Downs in the Healthcare Sector

Warby Parker Inc. (NYSE: WRBY), a leading name in the eyewear industry, is making waves with its innovative approach to providing eyewear products and services across the United States and..

GeneDx Holdings Corp. (WGS) Stock Analysis: Impressive Revenue Growth and a Rising Star in Genomics

GeneDx Holdings Corp. (WGS) is making waves in the healthcare sector, particularly in the diagnostics and research industry, with its advanced genetic testing services. Headquartered in Stamford, Connecticut, GeneDx has..

Metsera, Inc. (MTSR) Stock Analysis: A Biotech with a Promising 77% Upside Potential

Metsera, Inc. (NASDAQ: MTSR) is capturing the attention of investors with its promising pipeline in the biotechnology sector, primarily targeting obesity and related diseases. As a clinical-stage biotech company, Metsera..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds